NCT05684146 - Protect the Head to Head Study | Biotech Hunter

Enrollment

540

Participants

Timeline

Start Date

May 4, 2023

Primary Completion Date

October 31, 2024

Study Completion Date

December 31, 2024

Conditions

Embolism

Interventions

DEVICE

Emboliner Embolic Protection

Emboliner Embolic Protection Device will be used to capture and remove embolic material during transcatheter aortic valve replacement (TAVR) interventions

DEVICE

Sentinel Cerebral Protection

The Sentinel Cerebral Protection System will be used to capture and remove embolic material during transcatheter aortic valve replacement (TAVR) interventions

Trial Locations (2)

10032

RECRUITING

NewYork-Presbyterian/Columbia University Medical Center, New York

74104

RECRUITING

Oklahoma Heart Institute, Tulsa